{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:14:36Z","timestamp":1773144876954,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4662,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1093\/annonc\/mdl454","type":"journal-article","created":{"date-parts":[[2007,2,24]],"date-time":"2007-02-24T03:59:43Z","timestamp":1172289583000},"page":"453-460","source":"Crossref","is-referenced-by-count":57,"title":["The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"G.J.","family":"Weiss","sequence":"first","affiliation":[]},{"given":"R.","family":"Rosell","sequence":"additional","affiliation":[]},{"given":"F.","family":"Fossella","sequence":"additional","affiliation":[]},{"given":"M.","family":"Perry","sequence":"additional","affiliation":[]},{"given":"R.","family":"Stahel","sequence":"additional","affiliation":[]},{"given":"F.","family":"Barata","sequence":"additional","affiliation":[]},{"given":"B.","family":"Nguyen","sequence":"additional","affiliation":[]},{"given":"S.","family":"Paul","sequence":"additional","affiliation":[]},{"given":"P.","family":"McAndrews","sequence":"additional","affiliation":[]},{"given":"N.","family":"Hanna","sequence":"additional","affiliation":[]},{"given":"K.","family":"Kelly","sequence":"additional","affiliation":[]},{"suffix":"Jr","given":"P.A.","family":"Bunn","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl454_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0015","unstructured":"National Comprehensive Cancer NetworkNon-small cell lung cancer: clinical practice guidelines in oncology. Version 2. 2006. http:\/\/nccn.org\/professionals\/physician_gls\/PDF\/nscl.PDF (13 July 2006, date last accessed)."},{"key":"10.1093\/annonc\/mdl454_bb0020","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1200\/JCO.1998.16.7.2459","article-title":"Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study","volume":"16","author":"Wozniak","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2000.18.3.623","article-title":"Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial","volume":"18","author":"Bonomi","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0030","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1200\/JCO.1998.16.7.2459","article-title":"Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: a Southwest Oncology Group Study","volume":"16","author":"Cardenal","year":"1998","journal-title":"J Clin Oncol"},{"issue":"16S","key":"10.1093\/annonc\/mdl454_bb0035","article-title":"Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)","volume":"23","author":"Kosmidis","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/annonc\/mdi126","article-title":"Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin","volume":"16","author":"Pujol","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl454_bb0050","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1200\/JCO.2001.19.13.3210","article-title":"Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial","volume":"19","author":"Kelly","year":"2001","journal-title":"J Clin Oncol"},{"issue":"16S","key":"10.1093\/annonc\/mdl454_bb0055","article-title":"Randomized phase II\/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) Trial\u2014E4599","volume":"23","author":"Sandler","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0060","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1200\/JCO.2000.18.10.2095","article-title":"Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy","volume":"18","author":"Shepherd","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0065","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.2003.12.046","article-title":"Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group","volume":"21","author":"Fossella","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0070","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl454_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00031305.1996.10473544","article-title":"A comparison of approximate interval estimators for the Bernoulli parameter","volume":"50","author":"Leemis","year":"1996","journal-title":"Am Stat"},{"key":"10.1093\/annonc\/mdl454_bb0085","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1200\/JCO.2006.06.7835","article-title":"Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer","volume":"24","author":"Weiss","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0090","first-page":"1774","article-title":"Prognostic factors in advanced NSCLC: analysis of ECOG trials from 1981\u20131992","volume":"17","author":"Jiroutek","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdl454_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jama.296.2.218","article-title":"Women and Lung Cancer. Gender Equality at a Crossroad?","volume":"296","author":"Neugut","year":"2006","journal-title":"JAMA"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419378433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/3\/453\/1352943\/mdl454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T04:18:59Z","timestamp":1736828339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419378433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0923753419378433"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl454","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}